Novel Drug Delivery Systems to Treat Mild Traumatic Brain Injury Based on Carbon Nanotubes, University of Texas Health Science Center, University of Texas Medical Branch, Baylor College of Medicine, Rice University and Transitional Learning Center

AZONano -- Of the more than 1.5 million people who suffer a traumatic brain injury each year in the United States, as many as 75 percent sustain a concussion, a brain injury that is classified as mild yet can lead to long-term or permanent impairments and disabilities. A consortium of physicians and scientists in the Houston region is now undertaking a research initiative to improve diagnosis of mild traumatic brain injury (MTBI) and develop innovative treatment strategies.